1. Home
  2. CNTB vs WIMI Comparison

CNTB vs WIMI Comparison

Compare CNTB & WIMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • WIMI
  • Stock Information
  • Founded
  • CNTB 2012
  • WIMI 2015
  • Country
  • CNTB United States
  • WIMI China
  • Employees
  • CNTB N/A
  • WIMI N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • WIMI Computer Software: Prepackaged Software
  • Sector
  • CNTB Health Care
  • WIMI Technology
  • Exchange
  • CNTB Nasdaq
  • WIMI Nasdaq
  • Market Cap
  • CNTB 68.5M
  • WIMI 97.0M
  • IPO Year
  • CNTB 2021
  • WIMI 2020
  • Fundamental
  • Price
  • CNTB $1.17
  • WIMI $0.88
  • Analyst Decision
  • CNTB Strong Buy
  • WIMI
  • Analyst Count
  • CNTB 1
  • WIMI 0
  • Target Price
  • CNTB $8.00
  • WIMI N/A
  • AVG Volume (30 Days)
  • CNTB 24.6K
  • WIMI 408.8K
  • Earning Date
  • CNTB 09-05-2024
  • WIMI 01-01-0001
  • Dividend Yield
  • CNTB N/A
  • WIMI N/A
  • EPS Growth
  • CNTB N/A
  • WIMI N/A
  • EPS
  • CNTB N/A
  • WIMI N/A
  • Revenue
  • CNTB $24,116,000.00
  • WIMI $84,137,968.00
  • Revenue This Year
  • CNTB N/A
  • WIMI N/A
  • Revenue Next Year
  • CNTB $63.90
  • WIMI N/A
  • P/E Ratio
  • CNTB N/A
  • WIMI N/A
  • Revenue Growth
  • CNTB N/A
  • WIMI 19.25
  • 52 Week Low
  • CNTB $0.68
  • WIMI $0.56
  • 52 Week High
  • CNTB $2.84
  • WIMI $1.87
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 44.02
  • WIMI 47.40
  • Support Level
  • CNTB $1.18
  • WIMI $0.88
  • Resistance Level
  • CNTB $1.26
  • WIMI $0.90
  • Average True Range (ATR)
  • CNTB 0.07
  • WIMI 0.04
  • MACD
  • CNTB -0.01
  • WIMI -0.01
  • Stochastic Oscillator
  • CNTB 13.59
  • WIMI 26.76

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About WIMI WiMi Hologram Cloud Inc.

WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings primarily consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.

Share on Social Networks: